Laurion Capital Management LP Bausch Health Companies Inc. Put Options Transaction History

Laurion Capital Management LP

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 16, 2022	BUY	$21.6 - $27.79 $16 Million - $20.6 Million	740,000 New	740,000 $16.9 Million
Q2 2020 Aug 14, 2020	SELL	$13.31 - $20.51 $1.27 Million - $1.96 Million	-95,400 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$12.98 - $30.25 $1.24 Million - $2.89 Million	95,400 New	95,400 $1.48 Million
Q4 2019 Feb 13, 2020	SELL	$18.89 - $31.89 $7.56 Million - $12.8 Million	-400,000 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$20.52 - $26.45 $8.21 Million - $10.6 Million	400,000 New	400,000 $10.1 Million
Q1 2019 May 08, 2019	SELL	$20.23 - $26.29 $1.01 Million - $1.31 Million	-50,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$17.64 - $28.32 $10.1 Million - $16.2 Million	-570,700 Reduced 91.94%	50,000 $924,000
Q3 2018 Nov 13, 2018	BUY	$20.64 - $25.67 $12.8 Million - $15.9 Million	620,700 New	620,700 $15.9 Million

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.78B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.